Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

US Patent 10907215 · Granted Feb 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fl2025
Protein tyrosine phosphatase inhibitors2025
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fl2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
RET kinase inhibitors2024
RET kinase inhibitors2024
Compounds useful for inhibiting RET kinase2024